NewAmsterdam Pharma Company N.V. Warrant (NAMSW) financials · rev $22.5M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
NewAmsterdam Pharma Company N.V. Warrant (NAMSW) rev $22.5M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $22.5M | $45.6M |
| Operating Income | -$225.7M | -$176.3M |
| Net Income | -$203.8M | -$241.6M |
| EPS (Diluted) | -$1.72 | -$2.56 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $769.3M | $864.6M |
| Current Assets | $675.7M | $863.4M |
| Cash & Equivalents | $490.0M | $771.7M |
| PP&E | $383.0K | $242.0K |
| Total Liabilities | $85.9M | $107.1M |
| Current Liabilities | $85.8M | $106.9M |
| Shareholders' Equity | $683.4M | $757.5M |
| Retained Earnings | -$762.4M | -$558.6M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$147.8M | -$158.6M |
| CapEx | $246.0K | $672.0K |
| Investing Cash Flow | -$174.9M | -$62.8M |
| Financing Cash Flow | $29.5M | $659.5M |
| Free Cash Flow | -$148.0M | -$159.2M |
FAQ
What is NAMSW P/E and revenue?
NewAmsterdam Pharma Company N.V. Warrant (NAMSW) rev $22.5M.
What is NAMSW revenue?
NewAmsterdam Pharma Company N.V. Warrant last cached revenue is $22.5M (FY2025).
Is NAMSW profitable?
NewAmsterdam Pharma Company N.V. Warrant last cached net income is -$203.8M (FY2025).
What are NAMSW total assets?
NewAmsterdam Pharma Company N.V. Warrant last cached total assets are $769.3M (FY2025).
What is NAMSW free cash flow?
NewAmsterdam Pharma Company N.V. Warrant last cached free cash flow is -$148.0M (FY2025).
Not investment advice. Cached statements, not a live tape.